AngioDynamics

Founded in 1988 in Queensbury, N.Y., U.S., AngioDynamics is today a NASDAQ-listed public company. We are a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease. Our diverse product line includes market-leading radiofrequency ablation and NanoKnife® systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products.
AngioDynamics has distinguished itself as a dynamic brand in a technologically competitive, high-growth industry, through the company’s consistent ability to successfully develop and bring to market new technologies and products. AngioDynamics believes it is well poised to continue that trend. Looking into the future, the company plans to bring forth a continuing stream of innovations that greatly improve patient care by providing the highest-quality, best-performing products.

Company Growth (employees)
Type
Public
HQ
Latham, US
Size (employees)
1,300 (est)
AngioDynamics is headquartered in Latham, US

AngioDynamics Office Locations

AngioDynamics has an office in Latham
Latham, US (HQ)
14 Plaza Dr

AngioDynamics Metrics

AngioDynamics Financial Metrics

Revenue (2016)

$353.9 m

Revenue growth (2015-16), %

(1%)

Gross profit

$174.3 m

Gross profit margin (2016), %

49%

Net income (2016)

($43.6 m)

Market capitalization (21-Mar-2017)

$616.2 m

Closing share price (21-Mar-2017)

$16.9

Cash (31-May-2016)

$32.3 m
AngioDynamics's current market capitalization is $616.2 m.
AngioDynamics's revenue was reported to be $353.9 m in FY, 2016 which is a 0.9% decrease from the previous period.
FY, 2014FY, 2015FY, 2016

Revenue

$354.5 m$357 m$353.9 m

Revenue growth, %

1%(1%)

Cost of goods sold

$174.6 m$180.1 m$179.6 m

Gross profit

$179.9 m$176.9 m$174.3 m

Gross profit Margin, %

51%50%49%

Operating expense total

$166.4 m$177.9 m$173.3 m

EBIT

$13.4 m($994 k)$1 m

EBIT margin, %

4%(0%)0%

Interest expense

$3.7 m$3.2 m$3.4 m

Interest income

$4 k$11 k

Income tax expense

$3.3 m($4.7 m)$40.3 m

Net Income

$3.1 m($3.3 m)($43.6 m)
FY, 2014FY, 2015FY, 2016

Cash

$16.1 m$18.4 m$32.3 m

Accounts Receivable

Inventories

$61.1 m$67.4 m$55.4 m

Current Assets

$152.2 m$155.8 m$146.3 m

PP&E

$67.2 m$54.6 m$48.3 m

Goodwill

$360.3 m$361.3 m$361.3 m

Total Assets

$800.2 m$773.6 m$727.1 m

Accounts Payable

$32.9 m$23.7 m$15.6 m

Total Debt

$137.7 m$121.4 m

Current Liabilities

$72.3 m$61.2 m$66.7 m

Additional Paid-in Capital

$508.3 m$520.1 m$525.8 m

Retained Earnings

$32.7 m$28.2 m($16 m)

Total Equity

$545 m$507.2 m

Debt to Equity Ratio

0.3 x0.2 x

Debt to Assets Ratio

0.2 x0.2 x

Financial Leverage

1.4 x1.4 x
FY, 2014FY, 2015FY, 2016

Net Income

$3.1 m($3.3 m)($43.6 m)

Depreciation and Amortization

$16.8 m$17.9 m$18 m

Accounts Receivable

($15 m)$2.1 m$3.1 m

Inventories

($5.4 m)($6.2 m)$12 m

Accounts Payable

Cash From Operating Activities

$25.3 m$26.2 m$45.2 m

Purchases of PP&E

($11.8 m)($11.9 m)($2.3 m)

Cash From Investing Activities

($17 m)($13.3 m)($7.6 m)

Long-term Borrowings

($146.3 m)($20 m)($16.3 m)

Cash From Financing Activities

($14 m)($10.5 m)($23.7 m)

Interest Paid

$3.6 m$3.2 m$3.1 m

Income Taxes Paid

$182 k$699 k$332 k

AngioDynamics Market Value History

AngioDynamics Online Presence

AngioDynamics Company Life

You may also be interested in